key: cord-0724341-9x1ohtxt authors: Bhanuprasad, Kundakarla; Manesh, Abi; Devasagayam, Emily; Varghese, Lalee; Cherian, Lisa Mary; Kurien, Regi; Karthik, Rajiv; Deodhar, Divya; Vanjare, Harshad; Peter, Jayanthi; Michael, Joy S; Thomas, Meera; Samuel, Prasanna; Varghese, George M title: Risk Factors Associated with the Mucormycosis Epidemic During the COVID-19 Pandemic date: 2021-08-24 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.08.037 sha: 0d96a38a31cb5f236855de9d854300a8b38f36c1 doc_id: 724341 cord_uid: 9x1ohtxt This study assessed the risk factors driving the epidemic of COVID-19 associated mucormycosis (COVID-Mucor) in Indiathat accompanied the COVID-19 pandemic, particularly the second wave. We analysed the risk factors among 164 participants:132 COVID-Mucor(cases) and 32 non-COVID-Mucor(controls)using the data from a prospective cohort study of mucormycosis over oneyear. Diabetes mellitus remained a pivotal risk factor in both groups (97%) while uncontrolled diabetes mellitus (OR: 4.6; p=0.026)and newly detected diabetes (OR: 3.3; p=0.018), werecommoneramong the cases. Most patients with COVID-Mucor had mild COVID-19. Steroid use, often unwarranted, was highly associated with COVID-Mucorafter adjusting for other risk factors (OR 28.4; P 0.001). Serum ferritin was significantly higher(p=0.041), while C-reactive protein was not, suggesting that alterations in iron metabolism probably predispose to COVID-Mucor. Oxygen was used only in a small minority of patients with COVID-Mucor. The in-hospital mortality in both groups was low. In conclusion, the Indian COVID-Mucorepidemic was likely driven by a convergence of interlinked risk factors –uncontrolled diabetes mellitus, unwarranted steroid use, and perhapsCOVID-19 itself. Appropriate steroid use in patients with severe COVID-19 and screening and optimal control of hyperglycaemia can prevent COVID-Mucor. The COVID-19 pandemic in India, having caused29,500,000 confirmed cases and 374,000 deaths as of This study attempted to determine the risk factors for COVID-Mucorand the possible drivers ofthe surge of cases. This studyanalysed risk factors for COVID-Mucorfrom a prospective cohort database, thePOISE Mucor Study, at Christian Medical College, Vellore, a 3000-bedded teaching hospital in South Indiafrom 1 st July 2020 to 10 th June 2021 and was approved by the institutional review board and ethics committee (No. 12930/24.06.2020with the amendment approved on 24.07.2021). Patients aged 18years or older with clinical and imaging featuressuggestive of ROCM, confirmed by histopathology showing broad aseptate fungal hyphae with tissue damage and/or fungal culture confirming Mucorales were included. Cases were patients with COVID-19 confirmed by RT-PCR for SARS-CoV-2 on a nasopharyngeal sample within three months of mucormycosis.Patients with ROCM and negative RT-PCR for SARS-CoV-2were the controls.The variables (table 1) were compared between cases and controls using the Fisher exact and Wilcoxon rank-sum tests for categorical and continuous variables, respectively. Statistical significance was defined as a p-value <0.05. The mean age of the 164 patients (132 cases and 32controls) was 51 years, and 78% were men. Diabetes mellitus (present in 97%) remained a strong predisposing factor in both groups. Uncontrolled diabetes mellitus (HbA1c of >7.0%), 40% of which was newly detected, was associated with COVID-MUCOR (OR: 4.6; p=0.026). Diabetic ketoacidosis was only noted in the COVID-Mucor group, but this was not statistically significant. Median HbA1c was higher in the co-infected group, but this was also not significant. Steroid use was common, even in mild disease, and was strongly associated with COVID-Mucor (OR:38.3; p<0.001). The majority of these patients (53/74; 71.6%) received high dose steroids (>40mg prednisolone or equivalent) and methylprednisolone or dexamethasone was the most commonly used steroid.Oxygen use was uncommon among cases (14.4%). Serum ferritin was significantly higher among patients with COVID-Mucor (p=0.041); whereas C-reactive protein was not. Acute presentation of ROCM was commoner inCOVID-Mucor. The involvement of the brain and orbit were similar between groups. Multivariate analysis (table 2)revealed that steroid use was independently associated with COVID-Mucor (OR 28.4; p=0.001). India emerged as a hot-spot for COVID-Mucor during the second wave of the pandemic, documenting more than 4000 cases. This study showed that while traditional risk factors such as uncontrolled diabetes mellitus contributed, widespread use of steroids, even for mild COVID-19, was a major driver of COVID-Mucor. Additionally, there were pointers towards a complex interaction and confluence of various determinants, including possibly the COVID-19 infection itself. The high blood sugar, corticosteroids, and iron overload all lead to phagocyte dysfunction, likely the more immediate cause of mucormycosis. Most patients (97%) had underlying diabetes mellitus, which is higher than that (two-thirds of Finally, the recent surge in COVID-19 cases was associated with an unprecedented shortage in oxygen availability in India, resulting in the use of industrial-grade oxygen in some parts of the country. Although exposure to impure oxygen was thought to be a possible risk factor, in this study, only a fraction of patients required oxygen or ventilatory support, suggesting that it was unlikely a significant factor. The diagnosis of non-COVID-Mucor in this study was based on a single negative RT-PCR. Hence there is a small chance of misclassification of controls. In summary, the current Indian mucormycosis epidemic was precipitated by a unique confluence of risk factors -diabetes mellitus, widespread use of steroids, and perhapsCOVID-19 infection itself. Restricting steroid use to patients with severe COVID-19 requiring oxygen therapy, screening for and optimally controlling hyperglycaemia can prevent COVID-MUCOR in a large majority. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus JHU CSSE Coronavirus COVID-19 Global Cases et al The U-shaped association of serum iron level with COVID-19 severity: Is iron a potential therapeutic target? Diabetes and mucormycosis: a complex interplay Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India. Emerg Infect Dis Dexamethasone in Hospitalized Patients with Covid-19 The role of iron and iron chelators in zygomycosis Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention The authors would like to acknowledge Suresh Kumar, laboratory technician, for his technical support to the project. This work was supported by the institutional funds of the Christian Medical College, Vellore.